Paul Tudor Jones's GPCR Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 35,053 shares of Structure Therapeutics Inc. (GPCR) worth $2.44 M, representing 0.00% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Paul Tudor Jones has initiated a new position in GPCR, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Structure Therapeutics (GPCR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Structure Therapeutics (GPCR) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +35,053 | New Buy | 35,053 | $69.55 |
Paul Tudor Jones's Structure Therapeutics Investment FAQs
Paul Tudor Jones first purchased Structure Therapeutics Inc. (GPCR) in Q4 2025, acquiring 35,053 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Structure Therapeutics Inc. (GPCR) for 1 quarters since Q4 2025.
Paul Tudor Jones's largest addition to Structure Therapeutics Inc. (GPCR) was in Q4 2025, adding 35,053 shares worth $2.44 M.
According to the latest 13F filing for Q4 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 35,053 shares of Structure Therapeutics Inc. (GPCR), valued at approximately $2.44 M.
As of the Q4 2025 filing, Structure Therapeutics Inc. (GPCR) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Structure Therapeutics Inc. (GPCR) was 35,053 shares, as reported at the end of Q4 2025.